Estudo do CDC: Vacinas da Pfizer-BioNTech e Moderna reduzem o risco de hospitalização por Covid-19 em cerca de 64% após a primeira dose e 94% após a segunda dose entre adultos com 65 anos de idade ou mais

Effectiveness of Pfizer-BioNTech and Moderna Vaccines Against COVID-19 Among Hospitalized Adults Aged ≥65 Years — United States, January–March 2021 – CDC Morbidity and Mortality Weekly Report

Comentários: Pfizer/Moderna Vaccine Protection: 64% at First Dose, 94% at Second – HealthDay E Pfizer and Moderna vaccines reduce Covid-19 hospitalization risk by 94% among older adults, CDC study says – CNN

Comentário no Twitter

New @CDCMMWR has good news: mRNA COVID-19 vaccines (Pfizer-BioNTech, Moderna) reduced the risk of #COVID19-related hospitalization by 94% among fully vaccinated people 65+. CDC recommends getting a COVID-19 vaccine to prevent severe COVID-19 illness: https://t.co/W4SFuV6wQp. pic.twitter.com/Jf4ph2rl4s

— CDC (@CDCgov) April 28, 2021